Steglatro and Atorvastatin calcium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Steglatro (ertugliflozin) and Atorvastatin calcium (atorvastatin calcium). Common drug interactions include alopecia among females and colon cancer among males.

The phase IV clinical study analyzes what interactions people have when they take Steglatro and Atorvastatin calcium. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Steglatro?

Steglatro has active ingredients of ertugliflozin. eHealthMe is studying from 805 Steglatro users. Check the latest studies of Steglatro.

What is Atorvastatin calcium?

Atorvastatin calcium has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 77,309 Atorvastatin calcium users. Check the latest studies of Atorvastatin calcium.

On Jul, 15, 2026

15 people who take Steglatro and Atorvastatin calcium together, and have interactions are studied.

Steglatro and Atorvastatin calcium drug interactions.

What are the common drug interactions of Steglatro and Atorvastatin Calcium, by gender? *:

female:

Alopecia (absence of hair from areas of the body)
Arteriosclerosis (thickening and hardening of arteries)
Asthenia (weakness)
Back disorder
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Blood potassium decreased
Cardiac failure congestive
Contusion (a type of hematoma of tissue in which capillaries)
Decreased appetite
Depression

male:

Colon cancer
Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
Hypotension (abnormally low blood pressure)
Intestinal mass

What are the common drug interactions of Steglatro and Atorvastatin Calcium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Injection site pain

30-39:

Arteriosclerosis (thickening and hardening of arteries)
Cardiac failure congestive
Contusion (a type of hematoma of tissue in which capillaries)
Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Pituitary tumour

40-49:

n/a

50-59:

Epistaxis (bleed from the nose)
Inflammation
Injection site pain
Mass
Neck mass (mass in neck)
Rash
Swelling
Urine ketone body present

60+:

Disease progression
Pneumonia
Fatigue (feeling of tiredness)
Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
Hypersensitivity
Hypotension (abnormally low blood pressure)
Intestinal mass
Muscular weakness (muscle weakness)
Respiratory disorder (respiratory disease)
Sleep disorder

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 20.00%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 2 people, 13.33%
Asthma: 2 people, 13.33%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 6.67%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 6.67%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 1 person, 6.67%
Multiple Myeloma (cancer of the plasma cells): 1 person, 6.67%
Migraine Without Aura (headache without neurological problems): 1 person, 6.67%
Hidradenitis (chronic disease of a type of sweat gland): 1 person, 6.67%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Steglatro and Atorvastatin calcium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously